Xenon Pharmaceuticals Inc. SEC filings XENE
Xenon Pharmaceuticals Inc. has 800 filings in SEC EDGAR's recent list, going back to Aug 16, 2013. Its latest annual report, Form ARS, was filed on Apr 22, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 6, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Aug 6, 2026 (results of operations, regulation fd disclosure). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| S-8 POS | Filing | Jun 3, 2026 | — |
| S-8 POS | Filing | Jun 3, 2026 | — |
| S-8 POS | Filing | Jun 3, 2026 | — |
| S-8 POS | Filing | Jun 3, 2026 | — |
| S-8 POS | Filing | Jun 3, 2026 | — |
| S-8 POS | Filing | Jun 3, 2026 | — |
| S-8 POS | Filing | Jun 3, 2026 | — |
| S-8 POS | Filing | Jun 3, 2026 | — |
| S-8 POS | Filing | Jun 3, 2026 | — |
| S-8 POS | Filing | Jun 3, 2026 | — |
| S-8 | Employee stock plan registration | Jun 3, 2026 | — |
| S-8 | Employee stock plan registration | Apr 13, 2026 | — |
| 424B5 | Prospectus supplement | Mar 12, 2026 | — |
| FWP | Free writing prospectus | Mar 11, 2026 | — |
| 424B5 | Prospectus supplement | Mar 9, 2026 | — |
| 424B5 | Prospectus supplement | Feb 27, 2026 | — |
| S-8 | Employee stock plan registration | Dec 1, 2025 | — |
| S-8 | Employee stock plan registration | Feb 27, 2025 | — |
| S-3ASR | Automatic shelf registration | Aug 9, 2024 | — |
| S-8 | Employee stock plan registration | Jun 5, 2024 | — |
| 424B5 | Prospectus supplement | Nov 30, 2023 | — |
| 424B5 | Prospectus supplement | Nov 29, 2023 | — |
| 424B5 | Prospectus supplement | Jun 23, 2022 | — |
| 424B5 | Prospectus supplement | Jun 22, 2022 | — |
| S-8 | Employee stock plan registration | Jun 2, 2022 | — |
| 424B5 | Prospectus supplement | Mar 1, 2022 | — |
| 424B5 | Prospectus supplement | Oct 6, 2021 | — |
| FWP | Free writing prospectus | Oct 5, 2021 | — |
| 424B5 | Prospectus supplement | Oct 4, 2021 | — |
| S-3ASR | Automatic shelf registration | Oct 4, 2021 | — |
| 424B5 | Prospectus supplement | Mar 10, 2021 | — |
| 424B5 | Prospectus supplement | Mar 9, 2021 | — |
| 424B5 | Prospectus supplement | Aug 6, 2020 | — |
| S-3 | Shelf registration | Jun 3, 2020 | — |
| S-8 | Employee stock plan registration | Jun 3, 2020 | — |
| S-8 | Employee stock plan registration | Mar 9, 2020 | — |
| 424B5 | Prospectus supplement | Jan 23, 2020 | — |
| 424B5 | Prospectus supplement | Jan 22, 2020 | — |
| 424B5 | Prospectus supplement | Nov 5, 2019 | — |
| S-8 | Employee stock plan registration | Sep 13, 2019 | — |
| S-3 | Shelf registration | Aug 6, 2019 | — |
| S-8 | Employee stock plan registration | Mar 6, 2019 | — |
| 424B5 | Prospectus supplement | Sep 13, 2018 | — |
| 424B5 | Prospectus supplement | Sep 12, 2018 | — |
| 424B5 | Prospectus supplement | Jul 12, 2018 | — |
| 424B5 | Prospectus supplement | May 8, 2018 | — |
| S-8 | Employee stock plan registration | Mar 7, 2018 | — |
| S-8 | Employee stock plan registration | Mar 8, 2017 | — |
| 424B5 | Prospectus supplement | Sep 9, 2016 | — |
| FWP | Free writing prospectus | Sep 8, 2016 | — |
| 424B5 | Prospectus supplement | Sep 7, 2016 | — |
| S-8 | Employee stock plan registration | Mar 9, 2016 | — |
| S-3 | Shelf registration | Dec 7, 2015 | — |
| S-8 | Employee stock plan registration | Mar 16, 2015 | — |
| S-8 | Employee stock plan registration | Nov 5, 2014 | — |
| 424B4 | Prospectus | Nov 5, 2014 | — |
| S-1/A | Amended registration statement | Oct 9, 2014 | — |
| S-1/A | Amended registration statement | Oct 6, 2014 | — |
| S-1 | Registration statement | Sep 10, 2014 | — |
Showing 59 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- XENE (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- British Columbia, Canada
- Headquarters
- Burnaby
- SEC filer status
- Large accelerated filer
- SEC CIK
- 1582313
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.